Helicobacter Pylori UFT300
Quick Test

Test and report at the same time

Ultra-fast H. pylori detection from a biopsy The Biohit H. pylori UFT300 is a true quick test for the detection of H. pylori from a biopsy specimen. The biopsy taken during gastroscopy can be tested immediately to diagnose H. pyloriinfection or to determine the success of eradication therapy. The test results are ready in only 5 minutes enabling diagnosis and reporting at the same time. This saves the patient from an unnecessary visit to the doctor for hearing the test results. The Biohit H. pylori UFT300 quick test has excellent sensitivity and specificity which makes it a highly reliable and accurate tool for diagnostics.

Biohit H. pylori UFT300 featuring:

  • Ready-to-use test kit
  • Cup and plate versions available in kit sizes of 5 and 50 tests
  • Results ready in 5 min (both positive and negative
  • Storage room temperature
  • Sensitivity 94,5%, Specificity 100%
  • Testing and reporting during one appointment

Kit sizes:


  • 602005PLA (5 tests)
  • 602019PLA (50 tests)


  • 602005 (5 tests)
  • 602025 (20 tests)
  • 602019 (50 tests)
  • 602021 (100 tests)

N.B In the USA and Japan for research use only. For other countries, please check with your local Biohit distributor.

Helicobacter pylori infection is the most important cause of chronic gastritis. Another mechanism for gastritis and severe atrophic gastritis is the autoimmune mechanism, which can also be triggered by an H. pylori infection. This kit is intended to aid in the diagnosis of H. pylori infection.

Helicobacter pylori is a spiral shaped, gram-negative bacterium that colonizes the human stomach. The organism is found in the mucous layer of the stomach overlying the gastric epithelium and it does not appear to invade tissue. However, the mucosa underneath the area of the H. pylori colonization is invariably inflamed; this condition is referred to as chronic superficial or non-atrophic gastritis, which, if untreated, persists for life. Nevertheless, the chronic inflammatory process can lead to atrophic gastritis, which has been linked with peptic ulceration and gastric cancer, two of the most important diseases of the upper gastrointestinal tract.

The epidemiological evidence of a link between H. pylori infection and  gastric adenocarcinoma or mucosa associated lymphoid tissue (MALT) lymphoma has resulted in classification of the organism as a group I carcinogen.

ColonView Quick Test

Ideal tools for colorectal cancer screening

ColonView lateral flow quick test is intended for simple detection of fecal occult blood (FOB) in stool samples. The test is based on highly sensitive immunochemical detection of hemoglobin and hemoglobin/haptoglobin complex. The principal use of the Biohit ColonView Hb and Hb/Hp test is to screen for lower gastrointestinal (GI) pathologies, such as colorectal cancers and large adenomas that bleed. With the combination of two biomarkers, the ColonView quick test detects bleeding derived from both lower and upper gastrointestinal tract.

Test kit includes: The ColonView tests come in packs of 30 tests, each including test cassettes and well-equipped Sample Collection Kits that are given to the patient for home sample collection. Each collection kit includes a single Sample Collection Tube, instructions for use and a handy Stool Collection Paper.   The same sample can be used for both Hb and Hb/Hp testing.   ColonView Hb and Hb/Hp tests are simple, one step lateral flow tests that give results in 15 minutes.


  • Excellent screening tool for colorectal cancer and large adenomas that bleed 
  • Combined detection of hemoglobin (Hb) and hemoglobin/haptoglobin (Hb/Hp) complex
  • Detects bleeding from both lower and upper gastrointestinal tract
  • User-friendly Sample Collection Kit
  • Quick and simple single-step lateral flow test
  • 2-in-1 test cassette
  • High sensitivity for fecal occult blood detection
  • No dietary restrictions

N.B In the USA and Japan for research use only. For other countries, please check with your local Biohit distributor.

Quick test reader

The ColonView QT result can be confirmed with the help of the Biohit Quick test reader. Read more about this product from the Instruments pages.

ColonView Hb and Hb/Hp Fecal Occult Blood Test (FOB) test was designed to aid diagnosis of lower GI  pathologies, such as colorectal cancers and large adenomas that bleed. Colorectal cancer is one of  the  most commonly diagnosed cancers and a leading cause of cancer death in the United States. Screening  for colorectal cancer probably increases the cancer detection rate at an early stage, therefore reducing the mortality.

Lactose Intolerance Quick Test

The Lactose Intolerance Quick Test developed by Biohit for detecting lactose intolerance (hypolactasia of the small intestine) is based on the activity of the lactase enzyme in a biopsy specimen. The biopsy specimen taken from the mucosa of the upper part of the small intestine is examined immediately. The development of the color in the test liquid after 20 minutes informs whether or not the lactase enzyme is present in  the biopsy specimen. 

Lactose Intolerance Quick Test Kit consists of:

  • Reagents
  • Plates

Lactose Intolerance Quick Test Benefits:

  • Biopsy sample can be tested immediately
  • No instruments needed
  • Measures lactase activity directly
  • Simple two-step procedure
  • All reagents are ready for use
  • Easy visual interpretation
  • Results in 20 minutes
  • Severe hypolactasia can be differentiated from mild hypolactasia

N.B In the USA and Japan for research use only. For other countries, please check with your local Biohit distributor.

Lactose intolerance (hypolactasia) results in inability to digest lactose, the predominant sugar of milk. This inability results from a shortage of the lactase enzyme, which is produced in the small intestine. Lactase breaks down milk sugar (lactose) into simpler forms (glucose and galactose), which can then be absorbed into the bloodstream.

Lactase activity begins to decrease after weaning. One-third of the adult population worldwide retains the ability to digest lactose. It is estimated that approx. 15-20% of Western and Northern Europeans, and 90% of Asian, African and native Americans suffer from lactose intolerance. Often the symptoms remain undiagnosed, and, thus lactose intolerance may not be treated for years.